Has Luis Mignucci, MD received payments from drug or device companies?

Yes. Drug and device makers reported $194,744 in general payments to Luis Mignucci, MD across 191 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Luis Mignucci, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Luis Mignucci, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Luis Mignucci, MD

Neurological Surgery · Plano, TXNPI 1407801970

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $184,750 of the $194,744 with a category attached, or 94.9%. CTL Medical Corporation accounts for 97.1% of it on its own, with 12 other manufacturers making up the rest. Reporting peaked in 2019 at $104,898 and has fallen 99.5% since, to $519 in 2025. Among neurological surgery clinicians in TX with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$194,744in general payments, 2019–2025

Across 191 payments — averaging $1019.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

CTL Medical Corporation$189K
Abbott$4K
Nevro Corp.$503
7d Surgical Inc.$347
Johnson & Johnson$147
Orthofix Medical, Inc.$147
plus $471 from 7 others

$5,023in research payments, 2019–2025

Across 1 payment — averaging $5023.15 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Medtronic$5K

$336,546in ownership & investment interests, 2019–2025

Across 7 payments — averaging $48,078 each. An ownership or investment interest held by the physician or an immediate family member.

4web, Inc.$337K

What the payments were for

Consulting fees$184,75095%
Travel & lodging$3,8062%
Food & beverage$5,1873%
Gifts$1,0011%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
CTL Medical Corporation	32	$189,065
Abbott	129	$4,064
Nevro Corp.	11	$503
7d Surgical Inc.	2	$347
Johnson & Johnson(2 entities)	3	$147
Orthofix Medical, Inc.	4	$147
Brainlab, Inc.	2	$122
Omniscient Neurotechnology America Ltd	1	$114
Providence Medical Technology, Inc.	1	$102
Augmedics Inc.	2	$52
Kerecis Limited	1	$33
Globus Medical	2	$30
Arteriocyte Medical Systems, Inc.	1	$18

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$194,744 in reported general payments places this provider in the 90th percentile of 582 neurological surgery providers in Texas.

See all neurological surgery providers in Texas →

Medicare billing

Part B allowed, 2024

$186,979

Medicare patients

207

Services billed

1,268

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	49	$715
Gabapentin	49	$510
Methylprednisolone	49	$316
Acetaminophen-CodeineAcetaminophen With Codeine	16	$238
Tramadol Hcl	26	$188
Tizanidine Hcl	21	$90
Methocarbamol	18	$81
Cyclobenzaprine Hcl	15	$50

Paid to pharmacies, not to this prescriber.

Other neurological surgery in Plano

Rebecca StachniakPlano$561K
Richard WeinerPlano$225K
Koijan KainthThe Woodlands$1.3M
Luis DuarteSan Angelo$1.2M
Douglas FoxAustin$948K
Richard MeyratDallas$883K
Adam LewisCorpus Christi$792K
Arnold VardimanSan Antonio$687K
Andrew RoeserHouston$660K
Scott RobertsonRound Rock$606K

See the full list for Texas →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →